Related Experiment Videos

Clinical and cost comparison of ibutilide and direct-current cardioversion for atrial fibrillation and flutter

D K Murdock1, G T Schumock, J Kaliebe

  • 1Cardiovascular Associates of Northern Wisconsin, Wausau, USA.

Insights

Direct-current cardioversion is more effective and cost-efficient for restoring normal heart rhythm in recent-onset atrial fibrillation or flutter compared to intravenous ibutilide treatment. This study highlights DC cardioversion as the preferred clinical strategy.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Pharmacoeconomics

Background:

  • Atrial fibrillation and flutter are common arrhythmias.
  • Restoring sinus rhythm is a key treatment goal.
  • Anticoagulation is crucial before rhythm conversion.

Purpose of the Study:

  • To compare the clinical effectiveness of intravenous ibutilide versus direct-current cardioversion.
  • To evaluate the cost-effectiveness of each method for recent-onset atrial fibrillation/flutter.
  • To determine the optimal strategy for sinus rhythm restoration.

Main Methods:

  • Prospective comparison of two treatment strategies.
  • Inclusion of patients with recent-onset atrial fibrillation or flutter.
  • Assessment of success rates and healthcare costs.

Main Results:

  • Intravenous ibutilide demonstrated a low success rate for rhythm conversion.
  • Direct-current cardioversion achieved higher success rates.
  • Direct-current cardioversion was found to be more cost-effective.

Conclusions:

  • Direct-current cardioversion is the preferred method for restoring sinus rhythm.
  • Ibutilide is less effective and less cost-efficient for this indication.
  • Clinical guidelines should favor direct-current cardioversion for recent-onset arrhythmias.

Related Concept Videos